Announcements Trials
Browse Landscape

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 16INDUSTRY 2NETWORK 1

Study Type

Observational 2

Sponsor

Cancer Type

Gynecologic 2Breast 2

Conditions

Breast Neoplasms 468Neoplasms 316Carcinoma, Non-Small-Cell Lung 269Prostatic Neoplasms 215Colorectal Neoplasms 208Lung Neoplasms 178Multiple Myeloma 123Melanoma 110Carcinoma, Renal Cell 107Ovarian Neoplasms 94Carcinoma, Hepatocellular 78Pancreatic Neoplasms 69Urinary Bladder Neoplasms 65Stomach Neoplasms 64Neoplasm Metastasis 64Leukemia, Lymphocytic, Chronic, B-Cell 62Colonic Neoplasms 60Leukemia, Myeloid, Acute 53Uterine Cervical Neoplasms 50Recurrence 49Liver Neoplasms 46Lymphoma, Follicular 45Lymphoma 45Leukemia, Myelogenous, Chronic, BCR-ABL Positive 39Esophageal Neoplasms 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Lymphoma, Large B-Cell, Diffuse 35Hematologic Neoplasms 35Head and Neck Neoplasms 35Lymphoma, Non-Hodgkin 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Hereditary Breast and Ovarian Cancer Syndrome × Clear all
NCT04668521 2023-12-26

OVA360

Aspira Women's Health

Terminated
215 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

NCT01273909 2014-06-06

Outcomes After Perforator Flap Reconstruction for Breast Reconstruction and/or Lymphedema Treatment

The National Institute of Lymphology

Unknown
1,000 enrolled
BreastGynecologic

Breast Neoplasms, Lymphedema, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡